Q2 2025 · 13F-HR/A
SB INVESTMENT ADVISERS (UK) LTDholdings as filed
Filed 2025-11-14 · accession 0001493152-25-023523
$12.61B
Reported value
10
Positions
2025-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 22266T109 | CPNG | Coupang Inc | $9.27B | 73.5% | 309,542,259 | Common | SOLE |
| G4124C109 | GRAB | Grab Holdings Limited | $2.02B | 16.0% | 401,796,672 | Common | SOLE |
| G76279101 | ROIV | Roivant Sciences Ltd | $675.7M | 5.36% | 59,952,652 | Common | SOLE |
| 20464U100 | COMP | Compass Inc | $301.9M | 2.39% | 48,070,273 | Common | SOLE |
| 051774107 | AUR | Aurora Innovation Inc | $103.8M | 0.82% | 19,811,760 | Common | SOLE |
| 75943R102 | RLAY | Relay Therapeutics | $96.6M | 0.77% | 27,904,963 | Common | SOLE |
| 92764N102 | VIR | Vir Biotechnology | $84.1M | 0.67% | 16,684,041 | Common | SOLE |
| 35969L108 | YMM | Full Truck Alliance Co Ltd | $37.8M | 0.30% | 3,196,951 | Common | SOLE |
| 29280W109 | NRGV | Energy Vault Holdings Inc | $13.3M | 0.11% | 18,535,631 | Common | SOLE |
| 37611X209 | DNA | Ginkgo Bioworks Holdings Inc | $6.9M | 0.05% | 610,729 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.